TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
TVRD

Tvardi Therapeutics, Inc.

Healthcare · Biotechnology

1.30$ +19.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TVRD
Line item 2020 2021 2022 2023 2024 2025
– -8.9% -81.7% -40.1% +62.3% -26.8%
– -11.2% -74.5% -40.7% +67.5% -28.0%
– -57.5% +59.7% +6.7% +65.4% -45.3%
– -7.7% -73.8% -47.6% +65.4% -18.7%
– -44.2% +286.5% -9.8% +11.9% –
– – – – – –
– – – -12.3% -14.1% -16.4%
– -11.8% +361.5% -1.2% -45.6% -77.0%
– -4.7% -75.7% -23.3% +21.1% +178.0%
– +9.6% +14.0% -95.4% – –
– +15.0% -57.2% -33.1% -11.0% +124.5%
– – – – – –
– -8.6% -119.8% – – –
– – – – – –
– +5.9% +564.1% +0.0% -83.7% +411.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?